No interaction studies have been performed. Based on the biotransformation and elimination of faricimab (see Pharmacology: Pharmacokinetics under Actions), no interactions are expected. However, faricimab should not be administered concurrently with other systemic or ocular anti-VEGF medicinal products (see Precautions).